Aprotinin (Bayer)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAprotinin (Bayer)
Drug Alias Name牛胰蛋白酶抑制剂(拜耳)TrasylolBAYA-0128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitorsTrypsin inhibitors
TargetsTrypsinProtease
Therapy Area/IndicationsPostoperative HemorrhageBlood Loss, SurgicalHemorrhage
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1993/12/29
Country/TerritoryBelgiumCanadaUnited States +[13
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPostoperative HemorrhageBlood Loss, SurgicalHemorrhage

Other Information

ATC CodeB02AB01